Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets. The company offers orozyme, enzymatic toothpaste for dental care in cats and dogs; danilon, oral treatment for pain in horses; dinalgen, injectable treatment for pain in cattle, pigs and horses; aqupharm, dehydration treatment for cats, dogs, cattle, goats, horses, pigs, rabbits and sheep; Ulcershield, treatment and prevention of gastric ulcers in horses; daxocox, treatment of osteoarthritis pain and inflammation in dogs; plaqtiv+, biofilm-based dental care for cats and dogs; thiamacare, treatment for hyperthyroidism in cats; hemo, injectable nutritional solution for horses; and cosequin complementary feed for dogs and cats to strengthen and protect joints. The company has a collaboration with 272Bio Limited to develop and commercialize a novel biological treatment for a common equine skin condition, known as sweet itch. The company operates in Belgium, the Netherlands, the United Kingdom, Germany, Spain, Italy, Portugal, Australia, New Zealand, the United Arab Emirates and internationally. Animalcare Group plc is based in York, the United Kingdom.